A PHASE 1 STUDY OF IPI-926, AN INHIBITOR OF THE HEDGEHOG PATHWAY, IN PATIENTS (PTS) WITH ADVANCED OR METASTATIC SOLID TUMORSC. M. Rudin,G. J. Weiss,A. Chang, S. Gettinger,W. H. Miller,B. Eigl,A. Savage, G. Loewen,R. W. Ross,A. JimenoANNALS OF ONCOLOGY（2010）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
